Surgical resection of a sphenoid wing meningioma in a patient with Glanzmann thrombasthenia

Acta Anaesthesiologica Belgica

Volumn 62, Issue 2, 2011, Pages 83-86

  Wertz, Damien ^a   Boveroux, P ^a   Peters P ^a   Lenelle, J ^a   Franssen, C ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anti platelet antibodies; Bleeding; Glanzmann thrombasthenia; GPIIb IIIa; Inherited platelet disorders; Meningioma; Platelet transfusion; Recombinant activated factor VII; Treatment

Indexed keywords

ADULT; ANEMIA; ARTICLE; CASE REPORT; FEMALE; GLANZMANN DISEASE; HUMAN; MENINGIOMA; RASH; SPHENOID; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION;

ANTICOAGULANTS; FACTOR VIIA; FEMALE; HEMOSTATICS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RECOMBINANT PROTEINS; THROMBASTHENIA; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 80052821725     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Franchini M., Favaloro E. J., Lippi G., Glanzmann thrombasthenia : an update. CLIN. CHIM. ACTA, 411 (1-2), 1-6, 2010.
2. Nair S., et al., Glanzmann's thrombasthenia : updated, PLATELETS, 13 (7) : 387-93, 2002.
3. Kashiwagi H., et al., Molecular analysis of a patient with type I Glanzmann thrombasthenia and clinical impact of the presence of anti-alphaIIbbeta3 alloantibodies, INT. J. HEMATOL., 93 (1), 106-11, 2010.
4. Poon M. C., et al., Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia, BLOOD, 94 (11), 3951-3, 1999.
5. Hartmann M., Sucker C., Pharmacology and clinical use of recombinant activated factor seven in neurosciences, NEUROCRIT. CARE, 6 (2), 149-57, 2007. (Pubitemid 46934027)
6. Croom K. F., McCormack P. L., Recombinant factor VIIa (eptacog alfa) : a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders, BIODRUGS, 22 (2), 121-36, 2008. (Pubitemid 351414753)
7. Di Minno G., et al., Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3) : proposals for management between evidence and open issues, THROMB. HAEMOST., 102 (6), 1157-64, 2009.
8. Keeling D., Tait C., Makris M., Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology, HAEMOPHILIA, 14 (4), 671-84, 2008.
9. Lak M., et al., Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram, HAEMOPHILIA, 14 (1), 103-10, 2008.